|
TW201716062A
|
|
Use of monascus fermented product and secondary metabolites thereof in manufacture of composition for regulating blood sugar
|
|
CN106692128A
|
|
Compositions used for adjusting blood sugar
|
|
CN106265625A
|
|
Treatment and the compositions preventing Alzheimer disease
|
|
CN106267881A
|
|
Pure material extracting process
|
|
TW201639561A
|
|
Novel composition capable of treating and preventing Alzheimer's disease
|
|
TW201639478A
|
|
Extracting method
|
|
TW201617446A
|
|
Use of probiotic composition in manufacture of composition for ameliorating intestinal flora and reducing gastric mucosal lesion index
|
|
CN104673700A
|
|
Lactobacillus strain and primer group
|
|
TW201632623A
|
|
Blood pressure reducing composition and primer formonascus purpureusntu 568
|
|
CN104758535A
|
|
Composition for reducing blood pressure and primer set of monascus NTU 568
|
|
TW201526905A
|
|
Use of red mold dioscorea in manufacture of blood pressure reducing composition
|
|
US2013309731A1
|
|
Method for manufacturing red mold dioscorea
|
|
SG188692A1
|
|
Soymilk with additive of vitamin c, vitamin c salt or vitamin c stereoisomer
|
|
EP2574239A1
|
|
Soymilk with vitamin C additive
|
|
KR20130029890A
|
|
Composition for lowering blood lipid and elevating high-density lipoprotein and method for manufacturing the same
|
|
JP2013063925A
|
|
Mixture capable of reducing blood lipid and raising hdl cholesterol, and method for producing the same
|
|
US2013012576A1
|
|
Composition for Lowering Blood Lipid and Elevating High-density Lipoprotein and Method for Manufacturing the Same
|
|
CN102948484A
|
|
Vitamin C, vitamin C salt or vitamin C stereoisomer added soymilk
|
|
EP2559433A1
|
|
Method for manufacturing a composition for lowering blood lipid and elevating high-density lipoprotein.
|
|
TW201309215A
|
|
Soy milk having additive of vitamin c, vitamin c salt and vitamin c or vitamin c stereoisomers
|
